Article Text

Download PDFPDF

Cognitive function in patients with late stage amyotrophic lateral sclerosis
Free
  1. J Lakerveld1,2,
  2. B Kotchoubey1,
  3. A Kübler1
  1. 1
    Institute of Medical Psychology and Behavioural Neurobiology, University of Tübingen, Tübingen, Germany
  2. 2
    Institute of Health Sciences, Vrije Universiteit, Amsterdam, The Netherlands
  1. Dr J Lakerveld, Institute of Health Sciences, Vrije Universiteit, De Boeleaan 1085, 1081 HV Amsterdam, The Netherlands; j.lakerveld{at}vumc.nl

Abstract

Background: Subtle cognitive deficits have been found in a substantial percentage of patients with early stage amyotrophic lateral sclerosis (ALS). Cognitive function in later stages of the disease remain to be investigated because the neuropsychological tests that are usually employed, such as written or verbal fluency tests, cannot be performed by those patients because of motor or speech impairment, or both.

Methods: In the present study, 11 patients with late stage ALS who were severely physically impaired and matched controls underwent a neuropsychological test battery to explore their cognitive function with respect to disease related functional status. Testing was restricted to tasks that used a binary (yes/no) signal and did not require verbalisation or measures of reaction time to index performance.

Results: Although some patients displayed deficits in aspects of executive function, learning and memory, overall test results indicated normal cognitive function. A statistically highly significant negative correlation was found between the performance on two learning and memory tasks and the functional status of the patients.

Conclusion: The results of this study indicate a superior performance on learning and memory tasks of patients whose disease had further progressed. This may have important implications for our view on cognitive function in relation to the course of the disease.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Funding: This work was supported in part by grants from NIH in the USA (NICHD (HD30146) and NIBIB/NINDS (EB00856)), and the German Research Society (DFG) (SFB550) in Germany.

  • Competing interests: None.

  • 1 In this article, the results of patient No 10 were published to show the principle applicability of the newly compiled cognitive test battery. However, these results were neither included in any group statistics nor were they compared with control or normative data. This is why we chose to include this patient here.